Found: 24
Select item for more details and to access through your institution.
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022–August 2023.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 9, p. 1, doi. 10.1093/ofid/ofae481
- By:
- Publication type:
- Article
Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Infections—A Retrospective Study of Symptomatic Urinary Tract Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofy357
- By:
- Publication type:
- Article
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged =18 Years with Immunocompromising Conditions -- VISION Network, September 2023-February 2024.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 12, p. 271, doi. 10.15585/mmwr.mm7312a5
- By:
- Publication type:
- Article
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19--Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months--5 Years -- VISION Network, United States, July 2022--June 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 33, p. 886, doi. 10.15585/mmwr.mm7233a2
- By:
- Publication type:
- Article
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions -- VISION Network, September 2022-April 2023.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 21, p. 579, doi. 10.15585/mmwr.mm7221a3
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults -- VISION Network, Nine States, September-November 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 51/52, p. 1616, doi. 10.15585/mmwr.mm715152e1
- By:
- Publication type:
- Article
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 42, p. 1335, doi. 10.15585/mmwr.mm7142a4
- By:
- Publication type:
- Article
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated -- VISION Network, 10 States, December 2021-June 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 29, p. 931
- By:
- Publication type:
- Article
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 13, p. 495, doi. 10.15585/mmwr.mm7113e2
- By:
- Publication type:
- Article
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 7, p. 255, doi. 10.15585/mmwr.mm7107e2
- By:
- Publication type:
- Article
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance -- VISION Network, 10 States, August 2021-January 2022
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 139, doi. 10.15585/mmwr.mm7104e3
- By:
- Publication type:
- Article
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Clinical Profile of End-Stage AIDS.
- Published in:
- AIDS Patient Care & STDs, 1998, v. 12, n. 2, p. 125, doi. 10.1089/apc.1998.12.125
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 746, doi. 10.1093/cid/ciad704
- By:
- Publication type:
- Article
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 338, doi. 10.1093/cid/ciad505
- By:
- Publication type:
- Article
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1615, doi. 10.1093/cid/ciad003
- By:
- Publication type:
- Article
Evaluation of Online Risk Assessment To Identify Rabies Exposures Among Health Care Workers - Utah, 2019.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Human Rabies - Utah, 2018.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Estimating the Incidence of Influenza at the State Level -- Utah, 2016-17 and 2017-18 Influenza Seasons.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2019, v. 68, n. 50, p. 1158, doi. 10.15585/mmwr.mm6850a2
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 141, doi. 10.1093/infdis/jiad542
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 2, p. 185, doi. 10.1093/infdis/jiad015
- By:
- Publication type:
- Article
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 12, p. 1348, doi. 10.1093/infdis/jiad040
- By:
- Publication type:
- Article